BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16330577)

  • 1. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
    Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
    J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
    Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G
    J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
    Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
    Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
    Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):919-27. PubMed ID: 16572305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.
    Kersemans V; De Spiegeleer B; Mertens J; Slegers G
    Nucl Med Biol; 2006 Jan; 33(1):119-23. PubMed ID: 16459267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT.
    Mertens J; Kersemans V; Bauwens M; Joos C; Lahoutte T; Bossuyt A; Slegers G
    Nucl Med Biol; 2004 Aug; 31(6):739-46. PubMed ID: 15246364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments.
    Kersemans V; Vergote V; de Gelder V; Madani I; Thierens H; De Neve W; Mertens J; Slegers G; Burvenich C; Peremans K; De Spiegeleer B
    Cancer Biother Radiopharm; 2008 Apr; 23(2):192-201. PubMed ID: 18454688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.
    Bauwens M; Lahoutte T; Kersemans K; Gallez C; Bossuyt A; Mertens J
    Nucl Med Biol; 2006 Aug; 33(6):735-41. PubMed ID: 16934692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.
    Bauwens M; Wimana L; Keyaerts M; Peleman C; Lahoutte T; Kersemans K; Snykers S; Vinken M; Mertens J; Bossuyt A
    Cancer Biother Radiopharm; 2010 Apr; 25(2):225-31. PubMed ID: 20423236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats.
    Bauwens M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
    Contrast Media Mol Imaging; 2007 Jul; 2(4):172-7. PubMed ID: 17683118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
    Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of [123I]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma.
    Peremans K; Kersemans V; Liuti T; Vandermeulen E; Cornelissen B; Gielen I; De Spiegeleer B; Mertens J; Burvenich C; Slegers G
    Vet Radiol Ultrasound; 2007; 48(5):471-4. PubMed ID: 17899985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
    Bauwens M; Keyaerts M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
    Nucl Med Commun; 2007 Oct; 28(10):823-8. PubMed ID: 17728613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
    Kersemans V; Kersemans K; Cornelissen B; Staelens L; de Spiegeleer B; Mertens J; Slegers G
    Cancer Biother Radiopharm; 2006 Jun; 21(3):235-42. PubMed ID: 16918300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
    Samnick S; Romeike BF; Kubuschok B; Hellwig D; Amon M; Feiden W; Menger MD; Kirsch CM
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):532-41. PubMed ID: 14722685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
    Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H
    J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
    Lahoutte T; Mertens J; Caveliers V; Franken PR; Everaert H; Bossuyt A
    J Nucl Med; 2003 Sep; 44(9):1489-94. PubMed ID: 12960197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation in mice and metabolism in blood of human volunteers of [123I]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation.
    Dumont F; De Vos F; Versijpt J; Jansen HM; Korf J; Dierckx RA; Slegers G
    Eur J Nucl Med; 1999 Mar; 26(3):194-200. PubMed ID: 10079307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
    Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
    Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.